A multicenter, retrospective study evaluating efficacy and tolerability of perampanel in epilepsy patients in clinical setting.
Phase of Trial: Phase IV
Latest Information Update: 04 Dec 2018
At a glance
- Drugs Perampanel (Primary) ; Lamotrigine; Levetiracetam; Valproate
- Indications Seizures
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2018 Results presented at the 72nd Annual Meeting of the American Epilepsy Society
- 04 Dec 2018 Results presented in an Eisai Inc media release.
- 04 Dec 2018 According to an Eisai Inc media release, post-hoc analysis from this study were presented at the American Epilepsy Society Annual Meeting.